|
Volumn 4, Issue 2, 2000, Pages 65-66
|
On "supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: Primary outcomes".
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
EDITORIAL;
FEMALE;
HUMAN;
MALE;
MULTICENTER STUDY;
NEWBORN;
OXYGEN THERAPY;
RANDOMIZED CONTROLLED TRIAL;
RETROLENTAL FIBROPLASIA;
TREATMENT OUTCOME;
DISEASE PROGRESSION;
FEMALE;
HUMANS;
INFANT, NEWBORN;
MALE;
OXYGEN INHALATION THERAPY;
RETINOPATHY OF PREMATURITY;
TREATMENT OUTCOME;
|
EID: 0034170091
PISSN: 10918531
EISSN: None
Source Type: Journal
DOI: 10.1067/mpa.2000.105823 Document Type: Editorial |
Times cited : (10)
|
References (0)
|